VIA
ARNA

Vantage Investment Advisors’s Arena Pharmaceuticals Inc ARNA Stock Holding History

Vantage Investment Advisors’s Portfolio ARNA Stock Details ARNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q2 		– Sell
-10
Closed -$1K – 734
2014
Q1 		$1K Hold
10
– – ﹤0.01% 652
2013
Q4 		$1K Buy
+10
New +$523 ﹤0.01% 632

Other funds holding ARNA

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
O
OppenheimerFunds New York $80.4B AUM 15.1% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Vantage Investment Advisors's ARNA Position: Q2 2014 in Review

Vantage Investment Advisors sold out of Arena Pharmaceuticals Inc (ARNA) in Q2 2014, closing a stake of 10 shares — an estimated $1K sold.

Vantage Investment Advisors first reported a position in ARNA in Q4 2013 and held it in 2 quarters. The position peaked at $1K in Q1 2014. 129 funds tracked by Wall St. Rank hold ARNA as of Q2 2014.

  • Vantage Investment Advisors reported no remaining Arena Pharmaceuticals Inc position as of Q2 2014 after selling out during the quarter.
  • Vantage Investment Advisors sold 10 Arena Pharmaceuticals Inc shares in Q2 2014, an estimated $1K.
  • Vantage Investment Advisors first reported a position in Arena Pharmaceuticals Inc in Q4 2013 and held it in 2 quarters.
  • Vantage Investment Advisors's Arena Pharmaceuticals Inc position peaked at $1K in Q1 2014.
  • 129 funds tracked by Wall St. Rank held Arena Pharmaceuticals Inc as of Q2 2014.

Based on Vantage Investment Advisors's 13F filing for Q2 2014, filed 25 Jul 2014.